The Journal of Rheumatology 2024

4 papers
The 2024 volume of The Journal of Rheumatology emphasizes the intersection of oncology and rheumatology, specifically regarding immune-related adverse events. Research from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO), involving authors such as Carrie Ye and Shahin Jamal, investigates how age serves as a determinant of biological behavior in patients receiving immune checkpoint inhibitors. Notable work describes new clinical entities, such as remitting seronegative symmetrical synovitis with pitting edema, and explores the immunosenescence gap in therapeutic outcomes and vaccine efficacy. The edition also highlights the advancement of digital health and remote monitoring. Research explores the clinical validation of machine learning models and wearable sensing for tracking psoriatic arthritis and full-body kinematics. Additionally, the journal addresses the transition to virtual care by evaluating factors associated with telehealth appropriateness in rheumatoid arthritis encounters. Methodological themes include refining cohort selection, aligning research with patient-reported outcomes, and addressing the generalizability gap in clinical medicine. Prolific contributors to these themes include Janet Roberts, Marie Hudson, and Janet Pope.

Top Research Directions

The 11 research directions with The Journal of Rheumatology 2024 papers, ranked by paper count, next to 2023. Share is the fraction of the edition’s papers in the direction.

#Direction20242023Share 2024Share 20232023 rank
1Addressing Demographic Representation Gaps in Clinical AI1025.0%0.0%—
2Continuous Biomechanical Tracking with Wearable Inertial Sensors1025.0%0.0%—
3Developmental Stratification for Non Linear Biological Dynamics1025.0%0.0%—
4Diagnostic Masking from Altered Host Immune Responses1025.0%0.0%—
5Exclusionary Cohort Filtering for Confounder Isolation1025.0%0.0%—
6Mechanisms and Management of Refractory Inflammatory Phenotypes1025.0%0.0%—
7Overcoming Systemic Toxicity in Cancer Immunotherapy1025.0%0.0%—
8Robust Physiological Monitoring Under Severe Motion Artifacts1025.0%0.0%—
9Standardized Grading of Clinical Toxicities and Complications1025.0%0.0%—
10Statistical Power Limitations in Small Clinical Cohorts1025.0%0.0%—
11Tracking Dynamic Biomarker Trajectories Over Time1025.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by The Journal of Rheumatology 2024 papers: a paper credits every institution named in its affiliations, once. 20 institutions share 4 credited papers.

#InstitutionPapersShare20232023 rank
1Dalhousie University 250.0%0—
2McGill University 250.0%0—
3University of Alberta 250.0%14
4University of British Columbia 250.0%0—
5Brigham and Women's Hospital 125.0%17
6Duke University 125.0%0—
7Duke University Health System 125.0%0—
8Harvard Medical School 125.0%16
9New York University 125.0%0—
10NYU Grossman Long Island School of Medicine 125.0%0—
11NYU Langone Health 125.0%0—
12Sage Bionetworks 125.0%0—
13The University of Texas Southwestern Medical Center 125.0%0—
14UCB Pharma (Belgium) 125.0%0—
15University of Calgary 125.0%0—
16University of Ottawa 125.0%0—
17University of Pennsylvania 125.0%0—
18Université de Montréal 125.0%0—
19Université Libre de Bruxelles 125.0%0—
20Western University 125.0%0—

Download all institutions as CSV

About this data

Papers. The Journal of Rheumatology 2024 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2023 use shares, since the edition went from 4 to 4 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 4 of 4 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “The Journal of Rheumatology 2024”, https://lacuna.tiptreesystems.com/venue/the-journal-of-rheumatology/2024.

Top Authors

AuthorPapers
Carrie Ye2
Ricardo Henao1

Impactful Papers

Papers from The Journal of Rheumatology 2024 that shaped research clusters.

Influential

Papers

Title
Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
Evaluating Factors Associated With Telehealth Appropriateness in Outpatient Rheumatoid Arthritis Encounters Using the Encounter Appropriateness Score for You (EASY)
Immune Checkpoint Inhibitor–Associated Remitting Seronegative Symmetrical Synovitis With Pitting Edema: Description of a New Entity by CanRIO